Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasma-derived Therapies Market Size Growth Rate by Type: 2018 VS 2023 VS 2033
1.2.2 Albumin
1.2.3 Immunoglobulin
1.2.4 Factor VIII
1.2.5 Others
1.3 Market by Application
1.3.1 Global Plasma-derived Therapies Market Growth by Application: 2018 VS 2023 VS 2033
1.3.2 Hemophilia
1.3.3 Primary Immunodeficiencies (PIDs)
1.3.4 Idiopathic Thrombocytopenic Purpura (ITP)
1.3.5 COVID-19
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plasma-derived Therapies Market Perspective (2018-2033)
2.2 Plasma-derived Therapies Growth Trends by Region
2.2.1 Global Plasma-derived Therapies Market Size by Region: 2018 VS 2023 VS 2033
2.2.2 Plasma-derived Therapies Historic Market Size by Region (2018-2023)
2.2.3 Plasma-derived Therapies Forecasted Market Size by Region (2024-2033)
2.3 Plasma-derived Therapies Market Dynamics
2.3.1 Plasma-derived Therapies Industry Trends
2.3.2 Plasma-derived Therapies Market Drivers
2.3.3 Plasma-derived Therapies Market Challenges
2.3.4 Plasma-derived Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasma-derived Therapies Players by Revenue
3.1.1 Global Top Plasma-derived Therapies Players by Revenue (2018-2023)
3.1.2 Global Plasma-derived Therapies Revenue Market Share by Players (2018-2023)
3.2 Global Plasma-derived Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Plasma-derived Therapies Revenue
3.4 Global Plasma-derived Therapies Market Concentration Ratio
3.4.1 Global Plasma-derived Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasma-derived Therapies Revenue in 2023
3.5 Plasma-derived Therapies Key Players Head office and Area Served
3.6 Key Players Plasma-derived Therapies Product Solution and Service
3.7 Date of Enter into Plasma-derived Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasma-derived Therapies Breakdown Data by Type
4.1 Global Plasma-derived Therapies Historic Market Size by Type (2018-2023)
4.2 Global Plasma-derived Therapies Forecasted Market Size by Type (2024-2033)
5 Plasma-derived Therapies Breakdown Data by Application
5.1 Global Plasma-derived Therapies Historic Market Size by Application (2018-2023)
5.2 Global Plasma-derived Therapies Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Plasma-derived Therapies Market Size (2018-2033)
6.2 North America Plasma-derived Therapies Market Growth Rate by Country: 2018 VS 2023 VS 2033
6.3 North America Plasma-derived Therapies Market Size by Country (2018-2023)
6.4 North America Plasma-derived Therapies Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Plasma-derived Therapies Market Size (2018-2033)
7.2 Europe Plasma-derived Therapies Market Growth Rate by Country: 2018 VS 2023 VS 2033
7.3 Europe Plasma-derived Therapies Market Size by Country (2018-2023)
7.4 Europe Plasma-derived Therapies Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plasma-derived Therapies Market Size (2018-2033)
8.2 Asia-Pacific Plasma-derived Therapies Market Growth Rate by Region: 2018 VS 2023 VS 2033
8.3 Asia-Pacific Plasma-derived Therapies Market Size by Region (2018-2023)
8.4 Asia-Pacific Plasma-derived Therapies Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Plasma-derived Therapies Market Size (2018-2033)
9.2 Latin America Plasma-derived Therapies Market Growth Rate by Country: 2018 VS 2023 VS 2033
9.3 Latin America Plasma-derived Therapies Market Size by Country (2018-2023)
9.4 Latin America Plasma-derived Therapies Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasma-derived Therapies Market Size (2018-2033)
10.2 Middle East & Africa Plasma-derived Therapies Market Growth Rate by Country: 2018 VS 2023 VS 2033
10.3 Middle East & Africa Plasma-derived Therapies Market Size by Country (2018-2023)
10.4 Middle East & Africa Plasma-derived Therapies Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CSL Behring LLC
11.1.1 CSL Behring LLC Company Detail
11.1.2 CSL Behring LLC Business Overview
11.1.3 CSL Behring LLC Plasma-derived Therapies Introduction
11.1.4 CSL Behring LLC Revenue in Plasma-derived Therapies Business (2018-2023)
11.1.5 CSL Behring LLC Recent Development
11.2 Shire
11.2.1 Shire Company Detail
11.2.2 Shire Business Overview
11.2.3 Shire Plasma-derived Therapies Introduction
11.2.4 Shire Revenue in Plasma-derived Therapies Business (2018-2023)
11.2.5 Shire Recent Development
11.3 Bayer
11.3.1 Bayer Company Detail
11.3.2 Bayer Business Overview
11.3.3 Bayer Plasma-derived Therapies Introduction
11.3.4 Bayer Revenue in Plasma-derived Therapies Business (2018-2023)
11.3.5 Bayer Recent Development
11.4 Kedrion
11.4.1 Kedrion Company Detail
11.4.2 Kedrion Business Overview
11.4.3 Kedrion Plasma-derived Therapies Introduction
11.4.4 Kedrion Revenue in Plasma-derived Therapies Business (2018-2023)
11.4.5 Kedrion Recent Development
11.5 Takeda
11.5.1 Takeda Company Detail
11.5.2 Takeda Business Overview
11.5.3 Takeda Plasma-derived Therapies Introduction
11.5.4 Takeda Revenue in Plasma-derived Therapies Business (2018-2023)
11.5.5 Takeda Recent Development
11.6 Biotest
11.6.1 Biotest Company Detail
11.6.2 Biotest Business Overview
11.6.3 Biotest Plasma-derived Therapies Introduction
11.6.4 Biotest Revenue in Plasma-derived Therapies Business (2018-2023)
11.6.5 Biotest Recent Development
11.7 Octaparma
11.7.1 Octaparma Company Detail
11.7.2 Octaparma Business Overview
11.7.3 Octaparma Plasma-derived Therapies Introduction
11.7.4 Octaparma Revenue in Plasma-derived Therapies Business (2018-2023)
11.7.5 Octaparma Recent Development
11.8 Bio Products Laboratory (BPL)
11.8.1 Bio Products Laboratory (BPL) Company Detail
11.8.2 Bio Products Laboratory (BPL) Business Overview
11.8.3 Bio Products Laboratory (BPL) Plasma-derived Therapies Introduction
11.8.4 Bio Products Laboratory (BPL) Revenue in Plasma-derived Therapies Business (2018-2023)
11.8.5 Bio Products Laboratory (BPL) Recent Development
11.9 LFB
11.9.1 LFB Company Detail
11.9.2 LFB Business Overview
11.9.3 LFB Plasma-derived Therapies Introduction
11.9.4 LFB Revenue in Plasma-derived Therapies Business (2018-2023)
11.9.5 LFB Recent Development
11.10 Grifols
11.10.1 Grifols Company Detail
11.10.2 Grifols Business Overview
11.10.3 Grifols Plasma-derived Therapies Introduction
11.10.4 Grifols Revenue in Plasma-derived Therapies Business (2018-2023)
11.10.5 Grifols Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Plasma-derived Therapies Market Size Growth Rate by Type (US$ Million): 2018 VS 2023 VS 2033
Table 2. Key Players of Albumin
Table 3. Key Players of Immunoglobulin
Table 4. Key Players of Factor VIII
Table 5. Key Players of Others
Table 6. Global Plasma-derived Therapies Market Size Growth by Application (US$ Million): 2018 VS 2023 VS 2033
Table 7. Global Plasma-derived Therapies Market Size by Region (US$ Million): 2018 VS 2023 VS 2033
Table 8. Global Plasma-derived Therapies Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Plasma-derived Therapies Market Share by Region (2018-2023)
Table 10. Global Plasma-derived Therapies Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Plasma-derived Therapies Market Share by Region (2024-2033)
Table 12. Plasma-derived Therapies Market Trends
Table 13. Plasma-derived Therapies Market Drivers
Table 14. Plasma-derived Therapies Market Challenges
Table 15. Plasma-derived Therapies Market Restraints
Table 16. Global Plasma-derived Therapies Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Plasma-derived Therapies Market Share by Players (2018-2023)
Table 18. Global Top Plasma-derived Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma-derived Therapies as of 2023)
Table 19. Ranking of Global Top Plasma-derived Therapies Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Plasma-derived Therapies Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Plasma-derived Therapies Product Solution and Service
Table 23. Date of Enter into Plasma-derived Therapies Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Plasma-derived Therapies Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Plasma-derived Therapies Revenue Market Share by Type (2018-2023)
Table 27. Global Plasma-derived Therapies Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Plasma-derived Therapies Revenue Market Share by Type (2024-2033)
Table 29. Global Plasma-derived Therapies Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Plasma-derived Therapies Revenue Market Share by Application (2018-2023)
Table 31. Global Plasma-derived Therapies Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Plasma-derived Therapies Revenue Market Share by Application (2024-2033)
Table 33. North America Plasma-derived Therapies Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 34. North America Plasma-derived Therapies Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Plasma-derived Therapies Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Plasma-derived Therapies Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 37. Europe Plasma-derived Therapies Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Plasma-derived Therapies Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Plasma-derived Therapies Market Size Growth Rate by Region (US$ Million): 2018 VS 2023 VS 2033
Table 40. Asia-Pacific Plasma-derived Therapies Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Plasma-derived Therapies Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Plasma-derived Therapies Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 43. Latin America Plasma-derived Therapies Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Plasma-derived Therapies Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Plasma-derived Therapies Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 46. Middle East & Africa Plasma-derived Therapies Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Plasma-derived Therapies Market Size by Country (2024-2033) & (US$ Million)
Table 48. CSL Behring LLC Company Detail
Table 49. CSL Behring LLC Business Overview
Table 50. CSL Behring LLC Plasma-derived Therapies Product
Table 51. CSL Behring LLC Revenue in Plasma-derived Therapies Business (2018-2023) & (US$ Million)
Table 52. CSL Behring LLC Recent Development
Table 53. Shire Company Detail
Table 54. Shire Business Overview
Table 55. Shire Plasma-derived Therapies Product
Table 56. Shire Revenue in Plasma-derived Therapies Business (2018-2023) & (US$ Million)
Table 57. Shire Recent Development
Table 58. Bayer Company Detail
Table 59. Bayer Business Overview
Table 60. Bayer Plasma-derived Therapies Product
Table 61. Bayer Revenue in Plasma-derived Therapies Business (2018-2023) & (US$ Million)
Table 62. Bayer Recent Development
Table 63. Kedrion Company Detail
Table 64. Kedrion Business Overview
Table 65. Kedrion Plasma-derived Therapies Product
Table 66. Kedrion Revenue in Plasma-derived Therapies Business (2018-2023) & (US$ Million)
Table 67. Kedrion Recent Development
Table 68. Takeda Company Detail
Table 69. Takeda Business Overview
Table 70. Takeda Plasma-derived Therapies Product
Table 71. Takeda Revenue in Plasma-derived Therapies Business (2018-2023) & (US$ Million)
Table 72. Takeda Recent Development
Table 73. Biotest Company Detail
Table 74. Biotest Business Overview
Table 75. Biotest Plasma-derived Therapies Product
Table 76. Biotest Revenue in Plasma-derived Therapies Business (2018-2023) & (US$ Million)
Table 77. Biotest Recent Development
Table 78. Octaparma Company Detail
Table 79. Octaparma Business Overview
Table 80. Octaparma Plasma-derived Therapies Product
Table 81. Octaparma Revenue in Plasma-derived Therapies Business (2018-2023) & (US$ Million)
Table 82. Octaparma Recent Development
Table 83. Bio Products Laboratory (BPL) Company Detail
Table 84. Bio Products Laboratory (BPL) Business Overview
Table 85. Bio Products Laboratory (BPL) Plasma-derived Therapies Product
Table 86. Bio Products Laboratory (BPL) Revenue in Plasma-derived Therapies Business (2018-2023) & (US$ Million)
Table 87. Bio Products Laboratory (BPL) Recent Development
Table 88. LFB Company Detail
Table 89. LFB Business Overview
Table 90. LFB Plasma-derived Therapies Product
Table 91. LFB Revenue in Plasma-derived Therapies Business (2018-2023) & (US$ Million)
Table 92. LFB Recent Development
Table 93. Grifols Company Detail
Table 94. Grifols Business Overview
Table 95. Grifols Plasma-derived Therapies Product
Table 96. Grifols Revenue in Plasma-derived Therapies Business (2018-2023) & (US$ Million)
Table 97. Grifols Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Plasma-derived Therapies Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Plasma-derived Therapies Market Share by Type: 2023 VS 2033
Figure 3. Albumin Features
Figure 4. Immunoglobulin Features
Figure 5. Factor VIII Features
Figure 6. Others Features
Figure 7. Global Plasma-derived Therapies Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Plasma-derived Therapies Market Share by Application: 2023 VS 2033
Figure 9. Hemophilia Case Studies
Figure 10. Primary Immunodeficiencies (PIDs) Case Studies
Figure 11. Idiopathic Thrombocytopenic Purpura (ITP) Case Studies
Figure 12. COVID-19 Case Studies
Figure 13. Others Case Studies
Figure 14. Plasma-derived Therapies Report Years Considered
Figure 15. Global Plasma-derived Therapies Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Plasma-derived Therapies Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 17. Global Plasma-derived Therapies Market Share by Region: 2023 VS 2033
Figure 18. Global Plasma-derived Therapies Market Share by Players in 2023
Figure 19. Global Top Plasma-derived Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma-derived Therapies as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Plasma-derived Therapies Revenue in 2023
Figure 21. North America Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Plasma-derived Therapies Market Share by Country (2018-2033)
Figure 23. United States Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Plasma-derived Therapies Market Share by Country (2018-2033)
Figure 27. Germany Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Plasma-derived Therapies Market Share by Region (2018-2033)
Figure 35. China Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Japan Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. South Korea Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Southeast Asia Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. India Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Australia Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Plasma-derived Therapies Market Share by Country (2018-2033)
Figure 43. Mexico Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Brazil Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Plasma-derived Therapies Market Share by Country (2018-2033)
Figure 47. Turkey Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Saudi Arabia Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. CSL Behring LLC Revenue Growth Rate in Plasma-derived Therapies Business (2018-2023)
Figure 50. Shire Revenue Growth Rate in Plasma-derived Therapies Business (2018-2023)
Figure 51. Bayer Revenue Growth Rate in Plasma-derived Therapies Business (2018-2023)
Figure 52. Kedrion Revenue Growth Rate in Plasma-derived Therapies Business (2018-2023)
Figure 53. Takeda Revenue Growth Rate in Plasma-derived Therapies Business (2018-2023)
Figure 54. Biotest Revenue Growth Rate in Plasma-derived Therapies Business (2018-2023)
Figure 55. Octaparma Revenue Growth Rate in Plasma-derived Therapies Business (2018-2023)
Figure 56. Bio Products Laboratory (BPL) Revenue Growth Rate in Plasma-derived Therapies Business (2018-2023)
Figure 57. LFB Revenue Growth Rate in Plasma-derived Therapies Business (2018-2023)
Figure 58. Grifols Revenue Growth Rate in Plasma-derived Therapies Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed